Decision Support for Intraoperative Low Blood Pressure
Public ClinicalTrials.gov record NCT02726620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02726620
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Enrollment
- 22,435 participants
Conditions and interventions
Conditions
Interventions
- Attending real-time decision support Procedure
- In-room real-time decision support Procedure
- Attending feedback emails Procedure
- In-room provider feedback emails Procedure
- Anesthesia Information Management System (AIMS) Device
- Perioperative Data Warehouse (PDW) Device
- General anesthesia Procedure
- Pager system Device
- Central neuraxial anesthesia Procedure
- Non-cardiac surgery Procedure
- Propofol Drug
- Sevoflurane Drug
- Desflurane Drug
- Isoflurane Drug
- Ephedrine Drug
- Phenylephrine Drug
- Norepinephrine Drug
- Epinephrine Drug
- Dobutamine Drug
- Dopamine Drug
- Isoproterenol Drug
- Milrinone Drug
- Atropine Drug
- Glycopyrrolate Drug
- Vasopressin Drug
- Terlipressin Drug
- Sodium Chloride 0.9% Drug
- Ringer's lactate Drug
- Hydroxyethyl starch solutions Drug
- Fresh Frozen Plasma Drug
- Packed Red Blood Cells Drug
- Albumin solutions Drug
- Plasma-Lyte Drug
- Lidocaine Drug
- Bupivacaine Drug
- Levobupivacaine Drug
- Ropivacaine Drug
- Mepivacaine Drug
- Tetracaine Drug
- Prilocaine Drug
- Procaine Drug
- Chloroprocaine Drug
- Benzocaine Drug
- Articaine Drug
Procedure · Device · Drug
Eligibility (public fields only)
- Age range
- 60 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 4, 2017
- Primary completion
- Dec 30, 2017
- Completion
- Dec 28, 2018
- Last update posted
- May 15, 2019
2017 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02726620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02726620 live on ClinicalTrials.gov.